Dr. Kevin Ong will be speaking at the upcoming ABA Life Sciences Legal Summit. The event will be held on September 21, 2016 in San Francisco, CA.

The Third Annual Life Sciences Legal Summit will continue to enlighten attendees with practical insight regarding up-to-the-minute developments in the Life Sciences industries. Don't miss these cutting edge presentations by leading attorneys and industry experts in the biotechnology field.

Dr. Ong's presentation, 'Under the Watchful Eye of the FDA: What do FDA Warning Letters Tell Us' will provide a brief overview of quality system management and FDA inspections, as well as a retrospective analysis of FDA inspections and warning letters. The FDA provides oversight in the life sciences industry through inspections and audits of manufacturers, vendors/suppliers, and others to ensure compliance with quality systems. These quality systems provide a framework for manufacturers to achieve quality requirements for designing, manufacturing, packaging, labeling, storing, installing, and servicing of their products. Mr. John Fuson from Crowell & Moring LLP will be presenting this topic with Dr. Ong.

For more information, please visit the event website.

Exponent Inc. published this content on 21 September 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 September 2016 01:20:03 UTC.

Original documenthttp://www.exponent.com/newsevents/events/2016/09/aba-life-sciences

Public permalinkhttp://www.publicnow.com/view/ECA12DFED7B1A0200469B7F782AF4A129E729BED